Handbook of neurochemistry and molecular neurobiology neural membranes and transport /

Por Reith, Maarten E. A.
Publicado em 2007

Novel structure-function information on biogenic amine transporters revealed by site-directed mutagenesis and alkylation

Por Reith, Maarten E.A.
Publicado em 2013

Substrates dissociate dopamine transporter oligomers

Por Chen, Nianhang, Reith, Maarten E. A.
Publicado no J Neurochem (2007)

Impact of disruption of secondary binding site S(2) on dopamine transporter function

Por Zhen, Juan, Reith, Maarten E. A.
Publicado no J Neurochem (2016)

Functional properties of dopamine transporter oligomers after copper linking

Por Zhen, Juan, Reith, Maarten E. A.
Publicado no J Neurochem (2017)

Nitric oxide inhibits uptake of dopamine and N-methyl-4-phenylpyridinium (MPP(+)) but not release of MPP(+) in rat C6 glioma cells expressing human dopamine transporter

Por Cao, Bo-Jin, Reith, Maarten E A
Publicado em 2002

The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors

Por Schmitt, Kyle C., Reith, Maarten E. A.
Publicado em 2011

Correction: The Atypical Stimulant and Nootropic Modafinil Interacts with the Dopamine Transporter in a Different Manner than Classical Cocaine-Like Inhibitors

Por Schmitt, Kyle C., Reith, Maarten E. A.
Publicado em 2012

Dopamine and glutamate in psychiatric disorders

Por Schmidt, Werner J., Reith, Maarten E. A.
Publicado em c200

Importance of cholesterol in dopamine transporter function

Por Jones, Kymry T., Zhen, Juan, Reith, Maarten E.A.
Publicado em 2012

Structural Modifications of Neuroprotective Anti-Parkinsonian (−)-N6-(2-(4-(Biphenyl-4-yl)piperazin-1-yl)-ethyl)-N6-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine (D-264): A...

Por Modi, Gyan, Antonio, Tamara, Reith, Maarten, Dutta, Aloke
Publicado em 2014

Further delineation of hydrophobic binding sites in dopamine D(2)/D(3) receptors for N-4 substituents on the piperazine ring of the hybrid template 5/ 7-{[2-(4-Aryl- piperazin-1-yl...

Por Ghosh, Balaram, Antonio, Tamara, Gopishetty, Bhaskar, Reith, Maarten, Dutta, Aloke
Publicado em 2010

Nonclassical Pharmacology of the Dopamine Transporter: Atypical Inhibitors, Allosteric Modulators, and Partial Substrates

Por Schmitt, Kyle C., Rothman, Richard B., Reith, Maarten E. A.
Publicado em 2013

Latch and trigger role for R445 in DAT transport explains molecular basis of DTDS

Por Reith, Maarten E.A., Jones, Kymry T., Zhen, Juan, Topiol, Sid
Publicado no Bioorg Med Chem Lett (2017)

Interaction of catechol and non-catechol substrates with externally or internally facing dopamine transporters

Por Liang, Ying-Jian, Zhen, Juan, Chen, Nianhang, Reith, Maarten E.A.
Publicado em 2009

Concentration of receptor and ligand revisited in a modified receptor binding protocol for high-affinity radioligands: [(3)H]spiperone binding to D(2) and D(3) dopamine receptors

Por Zhen, Juan, Antonio, Tamara, Dutta, Aloke K., Reith, Maarten E.A.
Publicado em 2010

Discovery of 4-(4-(2-((5-hydroxy-1,2,3,4-tetrahydronaphthalen-2-yl)(propyl)amino)-ethyl)piperazin-1-yl)quinolin-8-ol and its analogues as highly potent dopamine D2/D3 agonists and...

Por Ghosh, Balaram, Antonio, Tamara, Reith, Maarten E. A., Dutta, Aloke K.
Publicado em 2010

Interrelation of dopamine transporter oligomerization and surface presence as studied with mutant transporter proteins and amphetamine

Por Li, Yan, Cheng, Shu-Yuan, Chen, Nianhang, Reith, Maarten E. A.
Publicado em 2010

Characterization of [(3)H]CFT binding to the norepinephrine transporter suggests that binding of CFT and nisoxetine is not mutually exclusive

Por Zhen, Juan, Ali, Solav, Dutta, Aloke K., Reith, Maarten E.A.
Publicado em 2011

Structure-activity-relationship study of N(6)-(2(4-(1H-indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine analogues: Development of highly...

Por Johnson, Mark, Antonio, Tamara, Reith, Maarten E. A., Dutta, Aloke K.
Publicado em 2012